GGRP GGRP
Company Profile ↓Company Overview
GGRP (GGRP) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 40.2% CAGR over the past five years.
Recent Developments
- Jun 2025 Revenue of $10.53M (+19.6% YoY); net profit $-2.55M.
- Trailing 12 Months Year-on-year growth — revenue +19.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 40.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 40.18% |
| 1 Year: | 19.58% |
Stock Price Performance
| 1 Year: | -36.31% |
| 6 Months: | +3.70% |
| 3 Months: | +75.05% |
| 1 Month: | +16.62% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)56.28 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 40.2% over 5 years.
CONS
- Trading 50.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 259.93K | 1.26M | 914.78K | 1.02M | 1.69M | 2.05M | 3.95M | 2.95M | 3.67M | 3.10M | 2.08M | 1.90M | 2.44M | 3.17M | 1.42M | 1.40M | 1.30M | 657.46K |
| Gross Profit | 122.80K | 713.65K | 320.19K | 877.15K | 1.48M | 1.68M | 2.74M | 2.08M | 2.45M | 1.92M | 1.42M | 1.33M | 1.92M | 2.02M | 1.02M | 1.01M | 789.47K | 584.10K |
| Operating Income | -1.24M | -693.38K | -1.26M | -1.40M | -1.58M | -2.38M | -5.43M | 1.23M | -5.28M | -170.72K | -812.47K | -1.60M | -1.03M | 6.93K | -1.58M | -1.34M | -1.26M | -12.71M |
| Net Income | -1.28M | -741.09K | -1.23M | -1.66M | -1.58M | -1.75M | -5.38M | 1.31M | -5.22M | -119.44K | -738.37K | -1.54M | -1.01M | 25.87K | -1.50M | -1.03M | -1.23M | -12.68M |
| Diluted EPS | - | - | - | - | -0.14 | - | -0.40 | 0.07 | -0.37 | -0.01 | -0.04 | -0.09 | -0.06 | 0.00 | -0.07 | -0.05 | -0.06 | -0.60 |
| R&D Expense | 736.75K | 588.77K | 669.01K | 989.38K | 1.19M | 1.91M | 2.00M | 2.53M | 2.16M | 1.68M | 1.39M | 1.14M | 1.12M | 659.70K | 829.82K | 973.40K | 894.39K | 1.53M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.95M | 3.42M | 7.27M | 13.48M | 8.80M | 10.53M |
| Gross Profit | 808.12K | 1.96M | 6.03M | 9.22M | 5.86M | 7.12M |
| Operating Income | -4.92M | -5.95M | -6.34M | -28.81M | -6.62M | -2.74M |
| Net Income | -4.99M | -6.09M | -5.97M | -28.56M | -6.39M | -2.55M |
| Diluted EPS | - | - | -0.51 | -2.05 | -0.38 | -0.13 |
| R&D Expense | 2.43M | 3.18M | 6.16M | 8.79M | 5.46M | 3.49M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2019 | Jun 2020 | Jun 2021 | Nov 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 2.00M | 3.22M | - | 38.40M | 24.28M | 15.56M | 19.28M |
| Total Equity | 1.47M | -305.69K | -1.17M | - | 28.82M | 11.22M | 11.54M | 16.94M |
| Cash & Equivalents | - | 1.03M | 1.77M | 11.50M | 16.25M | 5.62M | 1.85M | 6.83M |
| Total Liabilities | - | 2.30M | 4.39M | - | 9.58M | 13.05M | 4.02M | 2.34M |
| Current Liabilities | - | 570.50K | 2.34M | - | 4.24M | 8.13M | 2.43M | 2.34M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.02M | -1.21M | -4.94M | -9.16M | -5.21M | -273.77K |
| Investing Cash Flow | -32.66K | -28.00K | -5.06M | -3.53M | -1.53M | -1.54M |
| Financing Cash Flow | 1.89M | 1.97M | 26.48M | 66.11K | 2.97M | 6.80M |
| Capital Expenditure | -32.66K | -28.00K | -202.00K | - | -31.55K | -42.51K |
| Free Cash Flow | -2.06M | -1.24M | -5.14M | - | -5.24M | -316.28K |
Ratios (Annual)
Figures in %.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | 41.5% | 57.3% | 82.9% | 68.4% | 66.6% | 67.6% |
| Operating Margin % | -252.9% | -173.9% | -87.3% | -213.7% | -75.1% | -26.0% |
| Net Margin % | -256.7% | -178.0% | -82.1% | -211.9% | -72.6% | -24.2% |
| ROE % | 1,633.5% | 519.9% | -20.7% | -254.5% | -55.4% | -15.1% |
| ROCE % | -344.9% | -674.7% | -18.6% | -178.3% | -50.4% | -16.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GGRP
The Glimpse Group (GGRP) Abandons Its Original Business Model to Bet Everything on the Pentagon - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNMWFib3B5VU9KMEE3LUJndi1LbFpXc2pyU0VUeV9Fbm84Qkd2REV0Q04xaEN5RDZBLWZMc1dJaU1wVEsxbkxaWmFlaXRPb2plU0hjUGp3X1A3VGY2N0MxU2FFY1BBVXlodE5jbHRDWTNZNUxIRWVzNG5ZSFlvaTUtUUNMN3N5QS1SaUxlaF…
Glimpse Group (GGRP) grants ex-director over 97,000 stock options - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNOXdLelpDVVI1SWE0UkVHenUtMVVJTDAzVlJjRFd0eGV4YjI1MGtmcnlEX3NnUGtPeXZUeUU1MUlfZWhkRjN1SVJLd3ktZDhHUnlBNHRoa2JwWGl0RVJIS3hLSk1BT1lReHhjWU5haFlzMFI4bFNXM0NXZVpNSXJqWHdFRWlIdEszMlN6RV…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBWa3liZVplM3VDZ3VNS1dySDJ2eDU0ZTJhQUtZbFVDNzRCeUJUa0x6SzRzcl9BWlFCbXJKWVNUX0dnOE1Sb3pGMUxwUFFrTUh5?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
The Glimpse Group, Inc. (NASDAQ:GGRP) Is Expected To Breakeven In The Near Future - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNS0xuaEpHTE1nU0ZGdHhsRDdBWUNPU3pTRWJabzhlSm9abmwwN1VCa3ItQVA4QmZ4LWJOQmY0UnZoWjM5RWFSdUFCa2ppU1Zvb2kyUHBVNXUxZGlPdVJTbURIUkhJelZrWDB1dEQxWUJVRGIxd19lR2lkQjR2TVlQZXMzV3BsU1ZuZXpiVk…
PT Gunung Raja Paksi Tbk Revenue Breakdown – IDX:GGRP - TradingView
<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE45VEhkYjd5TlIxRGhzcjRzNUE1TVVFR2tuN0JWeWxJSzloT1lOMHVZWS1JMWU1WklkT2EtUGkwNk9hVWVNbVR2aXNqX1NFUEtJaVFaRVdHYjAxWVNvQ29UaE5say1WSE11VkdTMmdCSGpEa3c?oc=5" target="_blank">PT Gunung Ra…
The Glimpse Group, Inc. (NASDAQ:GGRP): Is Breakeven Near? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPdTFhMkpiajlOcEw5YktoOGd6NHRqOFBfRDRYemtaMzFpN2F5ejJHbmhxY1V5V3ptT1djSHdMYkpXNHRBQTNxOGFDNGd4ZEJrRXd2dG50ZktGY0ppdFE5OFpIaTk2Z2JMNG9NS05GQ1QwcjU2XzBJLVJuajhFWjU1Sm03S29XYTNCdU9STD…
GGRP — Frequently Asked Questions
What is the current share price of GGRP?
As of 2026-08-05 17:25 PDT, GGRP trades at $0.90 on NASDAQ/NYSE. Its 52-week range is $0.49 to $1.81.
What is the P/E ratio of GGRP?
GGRP trades at a trailing price-to-earnings (P/E) ratio of -6.92.
What is the return on equity (ROE) of GGRP?
GGRP has a return on equity (ROE) of -15.07%. Its return on capital employed (ROCE) is -16.19%.
Is GGRP a good stock to buy?
This page provides a data-driven analysis of GGRP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.